CD4 and cancer: RRS1 was related to B cells in 13 cancers, CD4+ T cells in 14 cancers, CD8+ T cells in 15 cancers, myeloid dendritic cells in 17 cancers, macrophages in 16 cancers, and neutrophils in 13 cancers according to TIMER analysis (Figure 12A).